Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI‐RADS v2

• Published in: Journal of magnetic resonance imaging Vol. 47; no. 4; pp. 1072 - 1079
• Main Authors: Yim, Jae Hyun, Kim, Chan Kyo, Kim, Jae‐Hun
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.04.2018
• Subjects: active surveillance; Aged; Cancer; Cancer research; Cancer surgery; Contrast Media; Cores; Diffusion coefficient; Diffusion Magnetic Resonance Imaging - methods; Field strength; Humans; Image Enhancement - methods; Imaging; Internationality; Magnetic resonance imaging; Magnetic Resonance Imaging - methods; Male; Medical research; Middle Aged; MRI; Multivariate analysis; Patients; PI‐RADS; PRIAS; Prostate - diagnostic imaging; Prostate cancer; Prostatectomy; Prostatic Neoplasms - diagnostic imaging; Radiology Information Systems; Retrospective Studies; Surveillance; prostate cancer; PRIAS; MRI; PI-RADS; active surveillance

Background Active surveillance (AS) is an important treatment strategy for prostate cancer (PCa). Prostate Imaging‐Reporting and Data System (PI‐RADS) v2 has been addressed, but few studies have reported the value of PI‐RADS v2 for assessing risk stratification in patients with PCa, especially on se...